Szydłowski, Radosław, et al. “PCSK9 Inhibitors – New Era of Dyslipidemia Treatment - Effectiveness in Reducing Low-Density Lipoprotein (LDL-C) and Cardiovascular Risk”. Quality in Sport, vol. 36, Dec. 2024, p. 56299, doi:10.12775/QS.2024.35.56299.